original ) (raw )2'5'-Bis-O-(tert-Butyldimethylsilyl)-3'Spiro5''- (4''Amino 1'',2''-Oxathiole-2'',2''Dioxide)Pyrimidine (TSAO) Nucleoside Analogues: Highly Selective Inhibitors of Human Immunodeficiency Virus Type 1 that are Targeted at the Viral Reverse Transcriptase
Ana Felix
Proceedings of The National Academy of Sciences, 1992
View PDFchevron_right
An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives
koen andries
Proceedings of the National Academy of Sciences, 1991
View PDFchevron_right
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase
T. Unge
Antimicrobial Agents and Chemotherapy, 1995
View PDFchevron_right
Promising novel compounds for the generation of new anti-HIV-RT therapeutic drugs
thiago souza
HIV Therapy, 2009
View PDFchevron_right
Abasic Analogues of TSAO-T as the First Sugar Derivatives That Specifically Inhibit HIV-1 Reverse Transcriptase
Carlos Pérez
Journal of Medicinal Chemistry, 1998
View PDFchevron_right
Synthesis, Biological Activity, and Crystal Structure of Potent Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase That Retain Activity against Mutant Forms of the Enzyme †
Kalyan Das
Journal of Medicinal Chemistry, 2007
View PDFchevron_right
Novel Thiazolidin-4-ones as Potential Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase
Athina Geronikaki
Molecules, 2019
View PDFchevron_right
Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase
Pinar Iyidogan , Kathleen Frey
ACS Medicinal Chemistry Letters, 2013
View PDFchevron_right
Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnuc...
Mj Perez
Proceedings of the National Academy of Sciences, 1993
View PDFchevron_right
Novel Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1)
palayakotai R raghavan
Journal of Medicinal Chemistry
View PDFchevron_right
[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1
María-josé Camarasa , Dominique Schols
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures
Carlos Alberto Montanari
Journal of computer-aided molecular design, 2002
View PDFchevron_right
Truncated Reverse Isoxazolidinyl Nucleosides: A New Class of Allosteric HIV-1 Reverse Transcriptase Inhibitors
Roberto Romeo
ChemMedChem, 2012
View PDFchevron_right
Slow, Tight-Binding HIV1 Reverse Transcriptase Non-Nucleoside Inhibitors Highly Active against Drug-Resistant Mutants
Gianluca SBARDELLA
Chemmedchem, 2007
View PDFchevron_right
TSAO Compounds: The Comprehensive Story of a Unique Family of HIV 1 Specific Inhibitors of Reverse Transcriptase
Ana Felix
Current Topics in Medicinal Chemistry, 2004
View PDFchevron_right
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitors
Jon H Condra
Antimicrobial Agents and Chemotherapy, 1992
View PDFchevron_right
[d4U]-Spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase
Roger Hunter
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Discovery of Non‐Nucleoside Inhibitors of HIV‐1 Reverse Transcriptase Competing with the Nucleotide Substrate
Marco Radi
Angewandte …, 2007
View PDFchevron_right
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
Huifang Dai
Bioorganic & Medicinal Chemistry, 2011
View PDFchevron_right
Chemical Barriers to Human Immunodeficiency Virus Type 1 (HIV1) Infection: Retrovirucidal Activity of UC781, a Thiocarboxanilide Nonnucleoside Inhibitor of HIV1 Reverse Transcriptase
Lady Belmont
1997
View PDFchevron_right
TSAO derivatives the first non-peptide inhibitors of HIV-1 RT dimerization
Ana San Felix
Antiviral chemistry & chemotherapy, 2005
View PDFchevron_right